by Jackie (née Heneghan) Peck | May 11, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
If you’re applying for a new Wholesale Distribution Authorisation – WDA(H) – you will need to have a Responsible Person or RP registered to the Authorisation. This person needs to be approved and registered by the MHRA. As a new wholesaler you can...
by Jackie (née Heneghan) Peck | May 10, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
What do you do with your old SOPs? Do you have space to store them in your office? Do you archive them? Do you have staff who work from home or in other countries? Do you save them digitally or in paper form? I am old enough to remember “Punch Cards “and “Microfiche”...
by Jackie (née Heneghan) Peck | May 10, 2014 | Blog, Community Pharmacy, Regulation
What are special measures and how do NHS TDA Monitor and CQC work together? What will happen when NHS TDA and Monitor place a trust in “Special measures”? CQC, through their chief inspector may recommend that a Trust is placed in special measures if they have evidence...
by Jackie (née Heneghan) Peck | Apr 25, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
Following on from news of the Co-Op’s decision to sell of its 750 pharmacies, Chemist & Druggist reported that a private consortium has raised approximately £40 m of the targeted £60 m required to commence their negotiations with the group. Whilst the group...
by Jackie (née Heneghan) Peck | Apr 25, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
As advisors to medicine wholesalers and pharmacies, we concern ourselves with maintaining the integrity of the supply chain. We stress the importance of being wary of falsified medicines and the pitfalls to look out for. Why is this product so cheap? Why is such a...
by Jackie (née Heneghan) Peck | Apr 16, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
One of the main changes seen in the recently issued European Commission Guidelines on Good Distribution Practices for medicines for human use (2013/C 343/01) is the emphasis on validating the entire supply chain to ensure that products that are temperature sensitive...
